Search

Your search keyword '"Laura Cortesi"' showing total 151 results

Search Constraints

Start Over You searched for: Author "Laura Cortesi" Remove constraint Author: "Laura Cortesi" Topic business.industry Remove constraint Topic: business.industry
151 results on '"Laura Cortesi"'

Search Results

1. The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance

2. Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9)

3. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

4. Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants’ characteristics at surgery: a prospective study

5. Pharmacist-driven medication recognition/ reconciliation in older medical patients

6. BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees

7. Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations

8. Postmenopausal hormone therapy in BRCA gene mutation carriers: to whom and which?

9. Inappropriate prescribing in intermediate care facilities

10. Potentially Inappropriate Medications, Drug–Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?

11. Abstract PD3-08: Effects of low dose tamoxifen on circulating risk biomarkers in a phase III trial in breast pre-invasive disease

12. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

13. Obesity in Postmenopausal Breast Cancer Patients: It Is Time to Improve Actions for a Healthier Lifestyle. The Results of a Comparison Between Two Italian Regions With Different 'Presumed' Lifestyles

14. Role of risk scoring systems in predicting life expectancy after carotid endarterectomy in asymptomatic patients

15. The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies

16. Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study

17. Orthostatic hypotension among elderly patients in Italian internal medicine wards: an observational study

18. Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?

19. Abstract P1-18-06: First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better?

20. BRCA mutation carriers' perceptions on postmenopausal hormone therapy: An Italian study

21. Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework

23. An Overview of PARP Inhibitors for the Treatment of Breast Cancer

24. Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy?

25. Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients

26. What changed in the Italian internal medicine and geriatric wards during the lockdown

27. Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers

28. Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer. A Randomized Clinical Trial

29. Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer

30. Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease

31. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants:Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

32. Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA

33. The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, study

34. Male bilateral risk-reducing mastectomy: Report of a case

35. The generally low sensitivity of CA 125 for FIGO stage I ovarian cancer diagnosis increases for endometrioid histotype

36. Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case report

37. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

38. Pain and Frailty in Hospitalized Older Adults

39. Breast ultrasonography (BU) in the screening protocol for women at hereditary-familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories?

40. Atrial Fibrillation: Possible Influences of Rate and Rhythm Control Strategy on Cognitive Performance

41. Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls

42. Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications

43. Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study

44. 203P Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer

45. Breast cancer screening of mutation carriers in the era of COVID‐19 pandemic

46. Drug prescriptions in nursing home residents: an Italian multicenter observational study

47. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients

48. First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis

49. Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia

50. Hereditary ovarian cancers: State of the art

Catalog

Books, media, physical & digital resources